We are live on
!
Find out more
AGP
Artia Global Partners Portfolio holdings
AUM
$444M
1-Year Est. Return
198.98%
This Fund
S&P 500
1 Year Est. Return
+198.98%
AUM
$444M
AUM Growth
-$179M
(-29%)
Holding
60
Top Buys
| 1 | +$8.13M | |
| 2 | +$5.39M | |
| 3 | +$5.26M | |
| 4 |
TERN
Terns Pharmaceuticals
TERN
|
+$4.3M |
| 5 |
Biogen
BIIB
|
+$3.4M |
Top Sells
| 1 | +$27.4M | |
| 2 | +$24.5M | |
| 3 | +$24.5M | |
| 4 |
SLNO
Soleno Therapeutics
SLNO
|
+$18.2M |
| 5 |
Viking Therapeutics
VKTX
|
+$17.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LYRA
51
DELISTED
LYRA THERAPEUTICS INC
LYRA
| – | – |
-8,756
|
|
||
52
Moderna
MRNA
$18.2B
| – | – |
0
|
|
||
53
Ocular Therapeutix
OCUL
$1.91B
| – | – |
-141,061
|
|
||
54
uniQure
QURE
$1.69B
| – | – |
-1,023,539
|
|
||
|
RNAM
55
DELISTED
Avidity Biosciences
RNAM
| – | – |
-60,100
|
|
||
56
ProShares Ultra Gold
UGL
$669M
| – | – |
-442,119
|
|
||
|
VTYX
57
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-695,982
|
|
||
58
Alto Neuroscience
ANRO
$691M
| – | – |
-29,192
|
|
||
|
UPB
59
Upstream Bio Inc
UPB
$342M
| – | – |
-68,653
|
|
||
|
PVLA
60
Palvella Therapeutics
PVLA
$1.47B
| – | – |
-59,200
|
|